Catalyst Pharmaceuticals Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Catalyst Pharmaceuticals stock have an average target of 32.5, with a low estimate of 29 and a high estimate of 36. The average target predicts an increase of 48.00% from the current stock price of 21.96.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$29	$32.5	$33	$36
Change	+32.06%	+48.00%	+50.27%	+63.93%

Analyst Ratings

The average analyst rating for Catalyst Pharmaceuticals stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	4	4	4	4	4	4
Buy	2	3	3	3	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	7	7	7	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joel Beatty Baird	Baird	Buy Maintains $28 → $32	Buy	Maintains	$28 → $32	+45.72%	Mar 3, 2025
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $35	Strong Buy	Reiterates	$35	+59.38%	Feb 28, 2025
Sudan Loganathan Stephens & Co.	Stephens & Co.	Buy Reiterates $33	Buy	Reiterates	$33	+50.27%	Feb 27, 2025
Joel Beatty Baird	Baird	Buy Initiates $28	Buy	Initiates	$28	+27.50%	Feb 4, 2025
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $30 → $35	Strong Buy	Maintains	$30 → $35	+59.38%	Jan 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

568.48M

from 491.73M

15.61%

from 491.73M

Revenue Next Year

644.91M

from 568.48M

13.44%

from 568.48M

EPS This Year

1.47

from 1.31

12.23%

from 1.31

EPS Next Year

1.80

from 1.47

22.38%

from 1.47

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	119.07M	140.83M	214.20M	398.20M	491.73M	568.48M	644.91M	733.07M
Revenue Growth	16.39%	18.27%	52.10%	85.90%	23.49%	15.61%	13.44%	13.67%
EPS	0.71	0.37	0.75	0.63	1.31	1.47	1.80	2.94
EPS Growth	136.67%	-47.89%	102.70%	-16.00%	107.94%	12.23%	22.38%	63.55%
Forward PE	-	-	-	-	-	14.94	12.20	7.46
No. Analysts	-	-	-	-	-	11	9	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	655.4M	746.6M	840.5M
Avg	568.5M	644.9M	733.1M
Low	520.0M	564.2M	629.9M

Revenue Growth

Revenue Growth	2025	2026	2027
High	33.3%	31.3%	30.3%
Avg	15.6%	13.4%	13.7%
Low	5.8%	-0.7%	-2.3%

EPS Forecast

EPS	2025	2026	2027
High	2.00	2.34	3.28
Avg	1.47	1.80	2.94
Low	1.12	1.35	2.60

EPS Growth

EPS Growth	2025	2026	2027
High	52.3%	59.3%	82.1%
Avg	12.2%	22.4%	63.5%
Low	-14.7%	-8.0%	44.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.